← Eichor
Condition: Moderate To Severe Asthma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Moderate To Severe Asthma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Se
NA · 1 location(s) · Poitiers University Hospital · NCT05691218ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Phase 2 · 14 location(s) · Enveda Therapeutics · NCT07301255Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06837922A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2 · 1 location(s) · Longbio Pharma · NCT07342803Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Phase 4 · 3 location(s) · University of California, San Diego · NCT06385236Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Phase 2 · 13 location(s) · Oneness Biotech Co., Ltd. · NCT05008965A Study of CM310 in Subjects With Moderate to Severe Asthma
Phase 2/Phase 3 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT05761028VENTURI (VENTilation Using Respiratory Imaging)
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT07282886A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
Phase 3 · 1 location(s) · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · NCT07372287A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Phase 2 · 132 location(s) · Pfizer · NCT06977581Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Phase 4 · 1 location(s) · Sally E. Wenzel MD · NCT04743791CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Phase 4 · 7 location(s) · Washington University School of Medicine · NCT07241117Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
Phase 2 · 1 location(s) · Keymed Biosciences Co.Ltd · NCT07011524A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · 121 location(s) · Eli Lilly and Company · NCT07219173
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.